1238
UTILIZING A NOVEL PRE-CLINICAL MOUSE MODEL OF EARLY ONSET EOSINOPHILIC ESOPHAGITIS THROUGH CONDITIONAL IL-13 OVEREXPRESSION TO ILLUMINATE THE ROLE OF TENASCIN-C IN PEDIATRIC EOSINOPHILIC ESOPHAGITIS
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
PROTEIN ADDUCTION REGULATE DNA DAMAGE RESPONSE IN PRENEOPLASTIC CONDITIONS OF ESOPHAGEAL ADENOCARCINOMA
The speakers in this session will provide insights into diverse molecular mechanisms of metaplasia, dysplasia and neoplasia across the esophagus, stomach, and colon…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA